Article

Drs. Galetta, Balcer to join NYU Langone

Steven L. Galetta, MD, has been appointed the Philip K. Moskowitz, MD, Professor and Chair of the department of neurology, and Laura Balcer, MD, MSCE, has been appointed vice chairwoman of the neurology department at the New York University (NYU) Langone Medical Center. The appointments are effective Nov. 1.

New York-Steven L. Galetta, MD, has been appointed the Philip K. Moskowitz, MD, Professor and Chair of the department of neurology, and Laura Balcer, MD, MSCE, has been appointed vice chairwoman of the neurology department at the New York University (NYU) Langone Medical Center. The appointments are effective Nov. 1.

Dr. Galetta will join NYU Langone from the University of Pennsylvania (UP), where he is the Ruth Wagner Van Meter and J. Ray Van Meter Professor of Neurology, vice chairman of the department, and director of the division of neuro-ophthalmology. He also leads the neuro-ophthalmology fellowship program.

Dr. Galetta has received nearly 50 awards, including the Christian R. and Mary F. Lindback Distinguished Teaching Award, UP’s highest teaching award. He was the recipient of the Louis Duhring Outstanding Clinical Specialist Award at UP in 1998. Dr. Galetta’s areas of expertise include research and advances in the treatment of double vision, neuro-ophthalmology, and optic nerve disorders. He has written more than 200 original papers and serves on the editorial boards of Neurology and the Journal of Neuro-Ophthalmology.

Dr. Balcer, who was a neuro-ophthalmology fellow under Dr. Galetta, was one of the first epidemiologists within the field of neuro-ophthalmology. She is an established clinical investigator whose research has focused on the development of visual outcome measures for multiple sclerosis (MS). Dr. Balcer’s studies, through collaborative efforts with investigators from several other institutions, first identified structure-function correlations in the visual pathway that now allow the measuring of axonal and neuronal loss in patients with MS and optic neuritis.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.